Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
326
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
-538K
-
Total reported value, excl. options
-
$5.84B
-
Value change
-
-$162M
-
Put/Call ratio
-
0.28
-
Number of buys
-
140
-
Number of sells
-
-181
-
Price
-
$312.59
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2019
395 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2019.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 326 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
.
Largest 10 shareholders include BlackRock Inc. (1.95M shares), VANGUARD GROUP INC (1.9M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (756K shares), AMERICAN CENTURY COMPANIES INC (749K shares), Levin Easterly Partners LLC (642K shares), WELLS FARGO & COMPANY/MN (602K shares), MILLENNIUM MANAGEMENT LLC (526K shares), STATE STREET CORP (494K shares), Russell Investments Group, Ltd. (411K shares), and UBS ASSET MANAGEMENT AMERICAS INC (397K shares).
This table shows the top 326 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.